ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 185057 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 185057; 2) Community: the network communities that were significantly associated with the response to NSC 185057; 3) Molecule: the relationships between components within communities and NSC 185057; 4) MDR: the compounds that were significantly associated with the NSC 185057.

NSC Compound Enrichment Correlation
NSC 756406 GW852849X 0.0385613993886001 0.38307594
NSC 756413 GW876790X 0.0385613993886001 -0.43355323
NSC 88916 10,13-dimethyl-17-(2-methyl-1,3-thiazol-4-yl)-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one 0.0385613993886001 0.32278372
NSC 93674 Oxyacanthan-7,12'-diol, 6,6'-dimethoxy-2,2'-dimethyl- 0.0385613993886001 0.41109301
NSC 111533 Methoxycamptothecin 0.0414190425892865 0.52011845
NSC 111702 p-Dioxane-2-methanol, 3,5-dihydroxy-6-[6-(methylthio)-9H-purin-9-yl]- 0.0414190425892865 0.25798443
NSC 116878 Cardiac glycoside 0.0414190425892865 0.32529928
NSC 123978 Sarveroside 0.0414190425892865 0.38259761
NSC 125845 Null 0.0414190425892865 0.5241282
NSC 134754 Null 0.0414190425892865 0.26052855
Total:100  Current:74    [First] [Prev] [Next] [Last]